A convincing lookalike of the popular Huorong Security antivirus has been used to deliver ValleyRAT, a sophisticated Remote ...

Microsoft details a new ClickFix variant abusing DNS nslookup commands to stage malware, enabling stealthy payload delivery ...

There is what Morgan Stanley refers to as a "thematically rich backdrop" to Europe and there are four key themes for investors to exploit: societal changes, geopolitical multipolarity, tech diffusion ...

Chinese hackers compromised Notepad++ updates for six months, deploying a backdoor to selectively target users in government and critical infrastructure sectors..

The cybersecurity community is still grappling with a sobering realization: one of the most ubiquitous tools in the developer’s toolkit, Notepad++, was hiding a critical vulnerability for over six ...

New AI tools from Anthropic sparked a broad sell-off in software and data stocks. Executives say fears are overblown, but analysts warn of margin and pricing pressure. Investors are reassessing which ...

At WSJ Invest Live, Jon Gray shared optimism for the health of the private-credit market and discussed Blackstone’s investment strategy in AI infrastructure. Investors’ fears that new developments in ...

Software stocks sold off dramatically after months of underperformance. The losses stemmed from fresh fears that AI models could upend the industry. Analysts say that while AI does pose a competitive ...

Monday - Friday, 6:00 - 7:00 PM ET There's a key metric that highlights why software stocks like ServiceNow are underperforming, according to Jim Cramer. He pointed to the decline in price-to-earnings ...

In this article, we will look at the 14 Best Software Stocks to Buy According to Wall Street Analysts. On January 29, Michael Sansoterra, Silvant Capital CIO, appeared on a CNBC Television interview ...

LONDON, Feb 5 (Reuters Breakingviews) - Public market investors are freaking out about artificial intelligence. Yet the pain may be even more dramatic in the worlds of private equity and credit.

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, ...